Use when an agent researches drugs, diseases or biotech sponsors, or watches tri...
https://1gateway.dev/v1/research/clinical-trialsOverview
Use when an agent researches drugs, diseases or biotech sponsors, or watches trial readouts. Input: condition, intervention (drug), sponsor or q (one or more), optional status, phase, limit, mode=catalysts with days (primary completion within N days, default 90). Output: JSON studies (NCT id, title, phases, status, enrollment, key dates, sponsor, conditions, interventions, countries, link). Example: ?condition=obesity&intervention=semaglutide&phase=3
Protocol
x402
Price
$0.01
Payment Asset
USD Coin
Payment Network
eip155:8453
Category
tools/search
Provider
1gateway
Source
bazaar
Indexed
2026-11-08 08:08:51
Health
Status
unknown
Latency (p50)
—
Uptime (30d)
—
Reliability Score
—
Last Checked
Never
Last Healthy
Never
Consecutive Failures
0
x402 Payment Validation
Payment Requirements
—
Asset Verified
—
Facilitator
—
Input Schema
{
"method": "GET",
"queryParams": {
"condition": "obesity",
"days": 90,
"intervention": "semaglutide",
"limit": 10,
"mode": "search",
"phase": "3",
"q": "GLP-1",
"sponsor": "Novo Nordisk",
"status": "recruiting,active"
},
"type": "http"
}
Output Schema
{
"example": {
"attribution": "Source: National Library of Medicine, ClinicalTrials.gov (https://clinicaltrials.gov). Records are submitted by study sponsors and investigators; NLM does not …",
"count": 3,
"notes": [
"Dates are as registered; '(ESTIMATED)' dates and enrollment can change. A primary completion date is when the primary outcome data are collected, not when resu…"
],
"query": {
"condition": "obesity",
"intervention": "semaglutide",
"limit": 3,
"mode": "search",
"phase": [
"PHASE3"
],
"q": null,
"sponsor": null,
"status": null
},
"sort": "last update, newest first",
"studies": [
{
"completionDate": "2028-12-05",
"conditions": [
"Diabetes Mellitus, Type 2"
],
"enrollment": 1300,
"enrollmentType": "ESTIMATED",
"hasResults": false,
"interventions": [
{
"name": "Maridebart cafraglutide",
"type": "DRUG"
}
],
"lastUpdated": "2026-11-05",
"locations": {
"count": 8,
"countries": [
"United States"
]
},
"nctId": "NCT07866066",
"phases": [
"PHASE3"
],
"primaryCompletionDate": "2028-09-06",
"sponsor": "Amgen",
"sponsorClass": "INDUSTRY",
"startDate": "2026-10-16",
"status": "RECRUITING",
"studyType": "INTERVENTIONAL",
"title": "Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes",
"url": "https://clinicaltrials.gov/study/NCT07866066"
}
],
"totalCount": 83
},
"type": "json"
}